Skip to search formSkip to main contentSkip to account menu

PAMP(1-20)NH2

Known as: Proadrenomedullin (1-20), Proadrenomedullin N Terminal 20 Peptide, Proadrenomedullin N-Terminal 20 Peptide 
National Institutes of Health

Related topics

Related topics

1 relation
adrenomedullin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study
BackgroundCommunity-acquired pneumonia (CAP) is a major cause of death worldwide and occurs with variable severity. There are few… 
2017
2017
MIDREGIONAL PROADRENOMEDULLIN: A PROGNOSTIC MARKER OF MORTALITY AND HEART FAILURE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
2016
2016
The effect of adrenomedullin and proadrenomedullin N-terminal 20 peptide on angiotensin II induced vascular smooth muscle cell proliferation
Objective(s): The study aimed to investigate the effects of adrenomedullin (ADM) and proadrenomedullin N- terminal 20 peptide… 
2016
2016
Midrange-proadrenomedullin in stable state predicts severe exacerbation of COPD
Background: Midrange-proadrenomedullin(MR-proADM), assessed in patients with clinically stable COPD, has been shown to be an… 
2015
2015
Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.
OBJECTIVES Chest pain is a common complaint to emergency departments (EDs) and clinical risk factors are used to predict which… 
Review
2014
Review
2014
Midregional proadrenomedullin for prognosis in community-acquired pneumonia: a systematic review.
2012
2012
Biomarkers associated with pulse pressure in African-Americans and non-Hispanic whites.
BACKGROUND Pulse pressure (an indirect measure of arterial stiffness) is a robust predictor of cardiovascular events, but its… 
2001
2001
The Mechanism of Proadrenomedullin N Terminal 20 Peptide in Reducing Blood Pressure
Objective: To elucidate the mechanism of proadrenomedullin N terminal 20 peptide (PAMP) in reducing blood pressure. Methods: PAMP… 
2000
2000
The role of proadrenomedullin N terminal 20 peptide in the regulation of blood pressure
Objective To elucidate the effect of proadrenomedullin N terminal 20 peptide (PAMP) in cardiovascular system and clinical… 
Highly Cited
1992
Highly Cited
1992
A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)